STAT3 and neoplasm: A small molecule inhibitor of STAT3 (WP1066) can reverse the immune tolerance of malignant glioma patients, selectively induce the expression of costimulatory molecules CD80, CD86, and IL-12 in peripheral blood and tumor-infiltrated macrophages, and induce macrophages to polarize to antitumor phenotype [109].